ATMP trials classification share by disease and development phase globally 2016

Classification of advanced therapy medicinal product (ATMP) trials worldwide as of 2016, by disease area and phase

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2016

Region

Worldwide

Survey time period

as of 2016

Supplementary notes

This statistic includes clinical trials from following databases: EudraCT (EU Drug Regulating Authorities Clinical Trials), ClinicalTrials.gov, and ICTRP (International Clinical Trials Registry Platform of the World Health Organization).
The table shows the number of ATMP trials in each disease area: cancer, cardiovascular diseases, immune system/inflammation, musculoskeletal system, neurology, GI diseases and diabetes, ophthalmology, pulmonology, dermatology, haematology, and others. In addition, it shows the percentage of ATMPs targeting every indication by phase of development.
* GI diseases: gastrointestinal diseases.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Cell and gene therapy "

Other statistics that may interest you Cell and gene therapy

Market overview

6

R&D/trials

5

Stem cells

5

Cord blood

5

CAR/CAR-T

4

Miscellaneous

5

Further related statistics

19
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.